Sensorion
Clinical-stage biotech developing novel therapies for inner ear disorders and hearing loss.
ALSEN | PA
Overview
Corporate Details
- ISIN(s):
- FR0012596468 (+2 more)
- LEI:
- 969500P0W8XJ9CGZDP97
- Country:
- France
- Address:
- 375 RUE DU PROFESSEUR BLAYAC, 34080 MONTPELLIER
- Website:
- https://www.sensorion.com/en/
Description
Sensorion is a clinical-stage biotechnology company specializing in the development of novel therapies for inner ear disorders. The company's mission is to address the significant unmet medical need of hearing loss by creating innovative therapeutic solutions. Its strategy is built on three pillars: restoring hearing through gene therapies for genetic diseases, treating existing hearing disorders with small molecule therapeutics, and preventing non-genetic hearing loss, such as drug-induced ototoxicity. Sensorion utilizes a unique R&D technology platform to advance its understanding of the pathophysiology of inner ear diseases and develop its pipeline of clinical candidates.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-03-21 07:30 |
Informations privilégiées / Autres communiqués
|
French | 134.7 KB | ||
| 2024-03-15 07:30 |
Informations privilégiées / Autres communiqués
|
French | 134.4 KB | ||
| 2024-03-15 07:30 |
Inside Information / Other news releases
|
English | 141.6 KB | ||
| 2024-03-14 07:35 |
Rapports financiers et d'audit annuels / Modalités de mise à disposition du rap…
|
French | 143.5 KB | ||
| 2024-03-14 07:35 |
Annual financial and audit reports / Terms of availability of the annual financ…
|
English | 150.8 KB | ||
| 2024-03-14 07:30 |
Inside Information / News release on accounts, results
|
English | 350.2 KB | ||
| 2024-03-14 07:30 |
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 329.7 KB | ||
| 2024-03-06 07:30 |
Inside Information / Other news releases
|
English | 124.7 KB | ||
| 2024-03-06 07:30 |
Informations privilégiées / Autres communiqués
|
French | 139.0 KB | ||
| 2024-02-29 07:30 |
Inside Information / Other news releases
|
English | 141.1 KB | ||
| 2024-02-29 07:30 |
Informations privilégiées / Autres communiqués
|
French | 134.1 KB | ||
| 2024-02-09 07:48 |
Inside Information / Other news releases
|
English | 425.8 KB | ||
| 2024-02-09 07:48 |
Informations privilégiées / Autres communiqués
|
French | 362.6 KB | ||
| 2024-02-01 07:30 |
Inside Information / Other news releases
|
English | 150.2 KB | ||
| 2024-02-01 07:30 |
Informations privilégiées / Autres communiqués
|
French | 140.2 KB |
Automate Your Workflow. Get a real-time feed of all Sensorion filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Sensorion
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Sensorion via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-04-11 | N/A | Other | Other | 2,781,914 | 1,752,605.82 EUR |
| 2024-04-11 | N/A | Other | Other | 1,587,301 | 999,999.63 EUR |
| 2024-02-13 | N/A | Other | Other | 16,842,105 | 9,599,999.85 EUR |
| 2024-02-08 | N/A | Other | Other | 12,280,701 | 6,999,999.57 EUR |
| 2023-08-08 | N/A | Other | Other | 46,428,571 | 12,999,999.88 EUR |
| 2023-08-03 | N/A | Other | Other | 25,000,000 | 7,000,000.00 EUR |
Peer Companies
